177 related articles for article (PubMed ID: 29770533)
1. Norcantharidin enhances antitumor immunity of GM-CSF prostate cancer cells vaccine by inducing apoptosis of regulatory T cells.
Mo L; Zhang X; Shi X; Wei L; Zheng D; Li H; Gao J; Li J; Hu Z
Cancer Sci; 2018 Jul; 109(7):2109-2118. PubMed ID: 29770533
[TBL] [Abstract][Full Text] [Related]
2. Norcantharidin combined with Coix seed oil synergistically induces apoptosis and inhibits hepatocellular carcinoma growth by downregulating regulatory T cells accumulation.
Wang D; Yang C; Wang Z; Yang Y; Li D; Ding X; Xu W; Zheng Q
Sci Rep; 2017 Aug; 7(1):9373. PubMed ID: 28839202
[TBL] [Abstract][Full Text] [Related]
3. Depletion of regulatory T cells by anti-ICOS antibody enhances anti-tumor immunity of tumor cell vaccine in prostate cancer.
Mo L; Chen Q; Zhang X; Shi X; Wei L; Zheng D; Li H; Gao J; Li J; Hu Z
Vaccine; 2017 Oct; 35(43):5932-5938. PubMed ID: 28923424
[TBL] [Abstract][Full Text] [Related]
4. Norcantharidin preferentially induces apoptosis in human leukemic Jurkat cells without affecting viability of normal blood mononuclear cells.
Liao HF; Su SL; Chen YJ; Chou CH; Kuo CD
Food Chem Toxicol; 2007 Sep; 45(9):1678-87. PubMed ID: 17442474
[TBL] [Abstract][Full Text] [Related]
5. Norcantharidin induces mitochondrial-dependent apoptosis through Mcl-1 inhibition in human prostate cancer cells.
Lin CL; Chen CM; Lin CL; Cheng CW; Lee CH; Hsieh YH
Biochim Biophys Acta Mol Cell Res; 2017 Oct; 1864(10):1867-1876. PubMed ID: 28760656
[TBL] [Abstract][Full Text] [Related]
6. Contribution of p38 MAPK Pathway to Norcantharidin-Induced Programmed Cell Death in Human Oral Squamous Cell Carcinoma.
Ahn CH; Hong KO; Jin B; Lee W; Jung YC; Lee H; Shin JA; Cho SD; Hong SD
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31315217
[TBL] [Abstract][Full Text] [Related]
7. Norcantharidin Induces Immunogenic Cell Death of Bladder Cancer Cells through Promoting Autophagy in Acidic Culture.
Xu L; Su B; Mo L; Zhao C; Zhao Z; Li H; Hu Z; Li J
Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409302
[TBL] [Abstract][Full Text] [Related]
8. A potential small-molecule synthetic antilymphangiogenic agent norcantharidin inhibits tumor growth and lymphangiogenesis of human colonic adenocarcinomas through blocking VEGF-A,-C,-D/VEGFR-2,-3 "multi-points priming" mechanisms in vitro and in vivo.
Li XP; Jing W; Sun JJ; Liu ZY; Zhang JT; Sun W; Zhu W; Fan YZ
BMC Cancer; 2015 Jul; 15():527. PubMed ID: 26187792
[TBL] [Abstract][Full Text] [Related]
9. Folate receptor-targeted liposomes loaded with a diacid metabolite of norcantharidin enhance antitumor potency for H22 hepatocellular carcinoma both in vitro and in vivo.
Liu MC; Liu L; Wang XR; Shuai WP; Hu Y; Han M; Gao JQ
Int J Nanomedicine; 2016; 11():1395-412. PubMed ID: 27110110
[TBL] [Abstract][Full Text] [Related]
10. Norcantharidin inhibits growth of human gallbladder carcinoma xenografted tumors in nude mice by inducing apoptosis and blocking the cell cycle in vivo.
Fan YZ; Zhao ZM; Fu JY; Chen CQ; Sun W
Hepatobiliary Pancreat Dis Int; 2010 Aug; 9(4):414-22. PubMed ID: 20688607
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effect of norcantharidin on the growth of human gallbladder carcinoma GBC-SD cells in vitro.
Fan YZ; Fu JY; Zhao ZM; Chen CQ
Hepatobiliary Pancreat Dis Int; 2007 Feb; 6(1):72-80. PubMed ID: 17287171
[TBL] [Abstract][Full Text] [Related]
12. Norcantharidin induces melanoma cell apoptosis through activation of TR3 dependent pathway.
Liu S; Yu H; Kumar SM; Martin JS; Bing Z; Sheng W; Bosenberg M; Xu X
Cancer Biol Ther; 2011 Dec; 12(11):1005-14. PubMed ID: 22123174
[TBL] [Abstract][Full Text] [Related]
13. Low-dose paclitaxel enhances the anti-tumor efficacy of GM-CSF surface-modified whole-tumor-cell vaccine in mouse model of prostate cancer.
He Q; Li J; Yin W; Song Z; Zhang Z; Yi T; Tang J; Wu D; Lu Y; Wang Z; Liu D; Zhang X; Hu Z; Gao J
Cancer Immunol Immunother; 2011 May; 60(5):715-30. PubMed ID: 21331814
[TBL] [Abstract][Full Text] [Related]
14. Norcantharidin induce apoptosis in human nasopharyngeal carcinoma through caspase and mitochondrial pathway.
Chen AW; Tseng YS; Lin CC; Hsi YT; Lo YS; Chuang YC; Lin SH; Yu CY; Hsieh MJ; Chen MK
Environ Toxicol; 2018 Mar; 33(3):343-350. PubMed ID: 29193574
[TBL] [Abstract][Full Text] [Related]
15. Norcantharidin induced DU145 cell apoptosis through ROS-mediated mitochondrial dysfunction and energy depletion.
Shen B; He PJ; Shao CL
PLoS One; 2013; 8(12):e84610. PubMed ID: 24367681
[TBL] [Abstract][Full Text] [Related]
16. Norcantharidin induces anoikis through Jun-N-terminal kinase activation in CT26 colorectal cancer cells.
Chen YJ; Kuo CD; Tsai YM; Yu CC; Wang GS; Liao HF
Anticancer Drugs; 2008 Jan; 19(1):55-64. PubMed ID: 18043130
[TBL] [Abstract][Full Text] [Related]
17. Norcantharidin combined with ABT-737 for hepatocellular carcinoma: Therapeutic effects and molecular mechanisms.
Ren J; Li G; Zhao W; Lin L; Ye T
World J Gastroenterol; 2016 Apr; 22(15):3962-8. PubMed ID: 27099439
[TBL] [Abstract][Full Text] [Related]
18. [Molecular mechanism of norcantharidin inducing apoptosis in liver cancer cells].
Li GQ; Zhang SJ; Lü JF; Wu Y; Li J; Zhang G; Yu JT
Zhonghua Yi Xue Za Zhi; 2010 Aug; 90(30):2145-8. PubMed ID: 21029633
[TBL] [Abstract][Full Text] [Related]
19. Primary in vitro and in vivo evaluation of norcantharidin-chitosan/poly (vinyl alcohol) for cancer treatment.
Li M; Xu X; Lu F; Guo S
Drug Deliv; 2014 Jun; 21(4):293-301. PubMed ID: 24156408
[TBL] [Abstract][Full Text] [Related]
20. Norcantharidin-blocked ANXA2P2 inhibits fibroblast proliferation by increasing UBAP2L mRNA stability through LIN28B.
Huang R; Yang Q; Wang T
Life Sci; 2021 Aug; 279():119645. PubMed ID: 34043991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
